Targeting allograft injury and inflammation in the management of post-lung transplant bronchiolitis obliterans syndrome

American Journal of Transplantation

Volumn 9, Issue 6, 2009, Pages 1272-1278

  Robertson, A G N ^a   Griffin, S M ^a   Murphy, D M ^b   Pearson, J P ^b   Forrest, I A ^b   Dark, J H ^a,b   Corris, P A ^b   Ward, C ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Antireflux surgery; Azithromycin; Bronchiolitis obliterans syndrome; Lung transplantation; Statin

Indexed keywords

AZITHROMYCIN; C REACTIVE PROTEIN; GELATINASE A; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 17; INTERLEUKIN 8; PROTON PUMP INHIBITOR; SIMVASTATIN;

ALLOGRAFT; ALLOIMMUNITY; ANTIREFLUX OPERATION; BRONCHIOLITIS OBLITERANS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY DISEASE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; INFLUENZA; LAPAROSCOPIC SURGERY; LUNG TRANSPLANTATION; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY;

AZITHROMYCIN; BRONCHIOLITIS OBLITERANS; GASTROESOPHAGEAL REFLUX; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LUNG DISEASES; LUNG TRANSPLANTATION; PNEUMONIA; PNEUMONIA, ASPIRATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 66249091548     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02648.x     Document Type: Short Survey

References (49)

1. Belperio JA, Weigt SS, Fishbein MC, Lynch JP 3rd. Chronic lung allograft rejection: Mechanisms and therapy. Proc Am Thorac Soc 2009 6 : 108 121.
2. Vanaudenaerde BM, Meyts I, Vos R et al. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Eur Respir J 2008 32 : 832 843.
3. D'Ovidio F, Keshavjee S. Gastroesophageal reflux and lung transplantation. Dis Esophagus 2006 19 : 315 320. (Pubitemid 44390434)
4. Ward C, De-Soyza A, Keating DT, Lordan J, Egan JJ. Infection and bronchiolitis obliterans syndrome in lung transplant recipients. In : Verleden GM, Van Raemdonck D, Lerut T, Demedts M (eds). European Respiratory Monograph: Surgery for Non-neoplastic Disorders of the Chest: A Clinical Update, vol. 29. Lausanne, Switzerland : European Respiratory Society, 2004 : 44 54.
5. Ward C, Forrest IA, Murphy DM et al. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax 2005 60 : 865 871. (Pubitemid 41475217)
6. DiGiovine B, Lynch JP 3rd., Martinez FJ et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: Role of IL-8. J Immunol 1996 157 : 4194 4202. (Pubitemid 126449334)
7. Botha P, Archer L, Anderson RL et al. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 2008 85 : 771 774.
8. Vos R, Vanaudenaerde BM, Geudens N, Dupont LJ, Van Raemdonck DE, Verleden GM. Pseudomonal airway colonisation: Risk factor for bronchiolitis obliterans syndrome after lung transplantation? Eur Respir J 2008 31 : 1037 1045.
9. Vos R, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE, Verleden GM. Transient airway colonization is associated with airway inflammation after lung transplantation. Am J Transplant 2007 7 : 1278 1287. (Pubitemid 46643119)
10. Skindersoe ME, Alhede M, Phipps R et al. Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2008 52 : 3648 3663.
11. Tateda K, Comte R, Pechere JC, Kohler T, Yamaguchi K, Van Delden C. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2001 45 : 1930 1933. (Pubitemid 32466379)
12. Ward C, Camara M, Forrest I et al. Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients. Thorax 2003 58 : 444 446. (Pubitemid 36560949)
13. Young LR, Hadjiliadis D, Davis RD, Palmer SM. Lung transplantation exacerbates gastroesophageal reflux disease. Chest 2003 124 : 1689 1693. (Pubitemid 37433560)
14. Hadjiliadis D, Duane Davis R, Steele MP et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant 2003 17 : 363 368. (Pubitemid 36958199)
15. Blondeau K, V Mertens, BA Vanaudenaerde et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J 2008 31 : 707 713.
16. Benden C, Aurora P, Curry J, Whitmore P, Priestley L, Elliott MJ. High prevalence of gastroesophageal reflux in children after lung transplantation. Pediatr Pulmonol 2005 40 : 68 71. (Pubitemid 40917911)
17. Stovold R, Forrest IA, Corris PA et al. Pepsin, a biomarker of gastric aspiration in lung allografts: A putative association with rejection. Am J Respir Crit Care Med 2007 175 : 1298 1303. (Pubitemid 46905756)
18. Ward C, Forrest IA, Brownlee IA et al. Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts. Thorax 2005 60 : 872 874. (Pubitemid 41475218)
19. Li B, Hartwig MG, Appel JZ et al. Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants. Am J Transplant 2008 8 : 1614 1621.
20. Vos R, Blondeau K, Vanaudenaerde BM et al. Airway colonization and gastric aspiration after lung transplantation: Do birds of a feather flock together? J Heart Lung Transplant 2008 27 : 843 849.
21. Atkins BZ, Trachtenberg MS, Prince-Petersen R et al. Assessing oropharyngeal dysphagia after lung transplantation: Altered swallowing mechanisms and increased morbidity. J Heart Lung Transplant 2007 26 : 1144 1148. (Pubitemid 350088507)
22. Zheng L, Walters EH, Ward C et al. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Thorax 2000 55 : 53 59. (Pubitemid 30248779)
23. Henke JA, Golden JA, Yelin EH et al. Persistent increases of BAL neutrophils as a predictor of mortality following lung transplant. Chest 1999 115 : 403 409. (Pubitemid 29083048)
24. Walters EH, Reid D, Soltani A, Ward C. Angiogenesis: A potentially critical part of remodelling in chronic airway diseases? Pharmacol Ther 2008 118 : 128 137.
25. Burlingham WJ, Love RB, Jankowska-Gan E et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007 117 : 3498 3506. (Pubitemid 350097005)
26. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008 28 : 454 467.
27. Davis RD Jr., Lau CL, Eubanks S et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003 125 : 533 542. (Pubitemid 36373899)
28. Cantu E 3rd., Appel JZ 3rd., Hartwig MG et al. J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 2004 78 : 1142 1151 discussion 1142-1151.
29. Linden PA, Gilbert RJ, Yeap BY et al. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg 2006 131 : 438 446. (Pubitemid 43121569)
30. Kelly JJ, Watson DI, Chin KF, Devitt PG, Game PA, Jamieson GG. Laparoscopic Nissen fundoplication: Clinical outcomes at 10 years. J Am Coll Surg 2007 205 : 570 575. (Pubitemid 47446320)
31. Hartwig MG, Appel JZ, Davis RD. Antireflux surgery in the setting of lung transplantation: Strategies for treating gastroesophageal reflux disease in a high-risk population. Thorac Surg Clin 2005 15 : 417 427. (Pubitemid 40848605)
32. Shitrit D, Bendayan D, Gidon S, Saute M, Bakal I, Kramer MR. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 2005 24 : 1440 1443. (Pubitemid 41247833)
33. Gottlieb J, Szangolies J, Koehnlein T, Golpon H, Simon A, Welte T. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2008 85 : 36 41.
34. Gerhardt SG, McDyer JF, Girgis RE, Conte JV, Yang SC, Orens JB. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: Results of a pilot study. Am J Respir Crit Care Med 2003 168 : 121 125. (Pubitemid 37046642)
35. Yates B, Murphy DM, Forrest IA et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2005 172 : 772 775. (Pubitemid 41324235)
36. Knyazhitskiy A, Masson RG, Corkey R, Joiner J. Beneficial response to macrolide antibiotic in a patient with desquamative interstitial pneumonia refractory to corticosteroid therapy. Chest 2008 134 : 185 187.
37. Murphy DM, Forrest IA, Ward C et al. Effect of azithromycin on primary bronchial epithelial cells derived from stable lung allografts. Thorax 2007 62 : 834.
38. Vanaudenaerde BM, Wuyts WA, Geudens N et al. Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. Am J Transplant 2007 7 : 76 82.
39. Fietta AM, Meloni F. Lung transplantation: The role of azithromycin in the management of patients with bronchiolitis obliterans syndrome. Curr Med Chem 2008 15 : 716 723.
40. Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006 174 : 566 570. (Pubitemid 44330550)
41. Jaffe A, Francis J, Rosenthal M, Bush A. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 1998 351 : 420. (Pubitemid 28064175)
42. Ichimiya T, Takeoka K, Hiramatsu K, Hirai K, Yamasaki T, Nasu M. The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro. Chemotherapy 1996 42 : 186 191. (Pubitemid 26095173)
43. Yamasaki T, Ichimiya T, Hirai K, Hiramatsu K, Nasu M. Effect of antimicrobial agents on the piliation of Pseudomonas aeruginosa and adherence to mouse tracheal epithelium. J Chemother 1997 9 : 32 37. (Pubitemid 27127986)
44. Murphy DM, Forrest IA, Corris PA et al. Azithromycin attenuates effects of lipopolysaccharide on lung allograft bronchial epithelial cells. J Heart Lung Transplant 2008 27 : 1210 1216.
45. Sifrim D, Matsuo H, Janssens J, Vantrappen G. Comparison of the effects of midecamycin acetate and azithromycin on gastrointestinal motility in man. Drugs Exp Clin Res 1994 20 : 121 126. (Pubitemid 24211103)
46. Watts KL, Sampson EM, Schultz GS, Spiteri MA. Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts. Am J Respir Cell Mol Biol 2005 32 : 290 300. (Pubitemid 40478304)
47. Murphy DM, Forrest IA, Corris PA et al. Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients. Am J Physiol Lung Cell Mol Physiol 2008 294 : L592 L599.
48. Johnson BA, Iacono AT, Zeevi A, McCurry KR, Duncan SR. Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med 2003 167 : 1271 1278. (Pubitemid 36555101)
49. Alexeeff SE, Litonjua AA, Sparrow D, Vokonas PS, Schwartz J. Statin use reduces decline in lung function: VA Normative Aging Study. Am J Respir Crit Care Med 2007 176 : 742 747. (Pubitemid 47598474)